Top Biotechnology & Medical Research stocks in Australasia

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name	Market Cap	Price to Earnings TTM	Dividend Yield % TTM
TLXTelix Pharmaceuticals	AU$4.19bn	730.1	n/a
MSBMesoblast	AU$872.73m	n/a	n/a
CU6Clarity Pharmaceuticals	AU$731.97m	n/a	n/a
IMUImugene	AU$659.56m	n/a	n/a
OPTOpthea	AU$477.22m	n/a	n/a
IMMImmutep	AU$445.81m	n/a	n/a
PYCPYC Therapeutics	AU$358.36m	n/a	n/a
RACRace Oncology	AU$248.51m	n/a	n/a
CGSCogstate	AU$214.21m	27.69	n/a
PIQProteomics International Laboratories	AU$148.03m	n/a	n/a
DXBDimerix	AU$134.25m	n/a	n/a
PARParadigm Biopharmaceuticals	AU$100.18m	n/a	n/a
ALAArovella Therapeutics	AU$100.06m	n/a	n/a
OCCOrthocell	AU$75.72m	n/a	n/a
ACWActinogen Medical	AU$73.83m	n/a	n/a
PERPercheron Therapeutics	AU$72.12m	n/a	n/a
BITBiotron	AU$67.65m	n/a	n/a
PEBPacific Edge	NZ$71.34m	n/a	n/a
AGNArgenica Therapeutics	AU$56.52m	n/a	n/a
IIQInoviq	AU$53.37m	n/a	n/a